Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.
Journal: Journal of the National Cancer Institute
Published: February 28, 2026
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).
Journal: BMC medical informatics and decision making
Published: February 28, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.
Journal: Contemporary clinical trials
Published: December 12, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: March 01, 2023
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.
Journal: Journal of patient-reported outcomes
Published: February 24, 2020
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 04, 2019
R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study.
Journal: The Lancet. Haematology
Published: July 24, 2017
Acute Angle Closure Precipitated by Hemorrhage and Necrosis of a Large Uveal Melanoma in the Setting of Systemic Immunomodulatory Therapy.
Journal: Ocular oncology and pathology
Published: January 17, 2017
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.
Journal: British journal of haematology
Published: June 29, 2015
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
Journal: Neuro-oncology
Published: September 21, 2014
Last Updated: 09/26/2026